USSTOCK.TODAY
Market Closed
Log in Sign up
Company overview

What Does SenesTech (SNES) Do? – Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Summary

Updated August 15, 2026 · First published April 23, 2026

SenesTech (SNES) is a US-based company that sells rodent fertility control products, with the expansion of online direct-to-consumer sales and commercial customer channels serving as the key drivers of revenue and outlook. Stock price movements can be influenced by subscription-based recurring purchases, product adoption rate, and selling expense management.

Briefs · earnings · signals, first Subscribe

🏢 What kind of company is SenesTech?

SenesTech is a US-based company that has commercialized a fertility control approach to reduce the growth of rodent populations. Public company materials present an approach that leverages fertility control within an integrated pest management framework, with a focus on improving the long-term efficiency of rodent management.

Core products include rodent fertility control baits and related management solutions. The company runs online direct sales, field sales, and commercial sales through distributors and resellers in parallel, reaching multiple customer segments ranging from household consumers to pest control firms, as well as agricultural and municipal government demand.

💰 How does SenesTech make money?

Business SegmentRevenue ShareDescription
Retail product salesCoreEvolve and ContraPest rodent fertility control products
Online salesKey growth driverOnline orders and subscriptions for direct consumers and business customers
Field and distribution salesDiversification driverCommercial customer access through field sales, distributors, and resellers

SenesTech's revenue is generated from rodent fertility control product sales across online sales, field sales, and distributor and reseller channels. Recently, the company has continued a strategy of increasing the share of online direct-to-consumer and online business-to-business transactions, while also expanding its subscription-based recurring revenue base. As direct sales channels expand, there may be more room to manage pricing and customer relationships, but profitability can fluctuate depending on advertising efficiency, logistics costs, and the pace of new customer acquisition. Field and distribution channels complement commercial customer touchpoints and play a role in revenue diversification.

Sensesens SenesTech's market cap and company size.

Market cap stands at $4.7M, and the number of employees has not been disclosed.

SenesTech is a publicly listed company focused on a fertility control approach that differs from traditional extermination methods in the rodent management market. It operates online sales and commercial customer channels together, and the execution of product demand expansion and sales network building is central to the business case. Going forward, the establishment of recurring purchases, cost efficiency by channel, and the balance of cash usage are likely to become important criteria in evaluating corporate value.

📈 SenesTech outlook and stock price trends

1-Year Price Performance
Analyst Consensus
1.0
Sell Hold Strong Buy
Target Price $7 +675.9% Current $1
52-Week Price Range
$1
Low $1 High $5
vs. low +2.98% vs. high -83.82%

In the short term, online advertising spend, Amazon operating efficiency, subscription customer retention, and commercial customer order flow can affect revenue and margins. Mid- to long-term growth drivers include demand for non-lethal rodent management, expansion of e-commerce channels, and the broadening of applications across agriculture, municipal governments, and pest control operators. However, the pace of industry adoption of the new approach, product regulatory requirements, and the burden of selling expenses on a limited customer base are volatility factors. As online sales grow, the execution of pricing strategy and logistics management also becomes more important.

🎯 Key growth drivers
Growing demand for non-lethal rodent management
Expansion of online direct sales and subscription-based revenue
Broadening of commercial customer and agricultural applications

⚔️ SenesTech's core strengths and risks

A differentiated product approach based on rodent fertility control and channel diversification are strengths, while market adoption rate, regulation, and the burden of selling expenses are key risks.

💪 Core strengths

Fertility control approach
Provides a different option from traditional rodent extermination products by reducing population growth.
Channel diversification
Runs online sales, field sales, and distributor channels in parallel to broaden customer access paths.
Subscription-based expansion
Growth in recurring purchases and subscription customers can support revenue visibility and customer relationship management.

⚠️ Key risks

Adoption rate
The pest control industry may adopt the new technology more slowly than expected.
Regulatory environment
Changes in regulatory requirements by region and intended use of the product may constrain sales expansion.
Selling expense burden
Costs required for online advertising, logistics, and customer acquisition may delay profitability improvement.
SenesTech's competitors and related beneficiary stocks

The provided candidate group cannot be verified as direct competitors or related stocks based solely on public materials regarding business suitability for direct comparison with SenesTech's rodent fertility control products. Therefore, it is more appropriate to examine this company with a focus on the spread of its individual products, adoption in the pest management market, and the execution of online sales and commercial customer channels. Comparable companies should be selected separately after confirming similarity in product approach and customer segments.

TickerMarket CapPERPBRROEDividend YieldChange
SNES SNES$4.7M-0.8-107.41%--2.8%
BHP$234.5B23.84.620%3.15%+0.3%
LIN$215.1B30.15.518.67%1.38%-0.4%
SCCO$176.7B31.314.050.07%1.91%+0.3%
NEM$135.6B16.33.925.53%0.81%+1.3%
RIO$130.2B14.12.619.54%4.76%-0.1%
Industry avg-20.92.33.3%1.46%-

✅ SenesTech investor checkpoints

When reviewing SenesTech, it is necessary to check together whether demand for rodent fertility control products translates into actual orders, whether online sales and field sales complement each other, and whether recurring purchases from commercial customers are increasing. In particular, it is important to examine whether the expansion of sales channels improves profitability faster than the increase in costs.

CheckpointWhat to verifyCurrent status
🛒 Online salesOrder and subscription flow from direct consumers and business customersExpanding trend
🏢 Commercial customersWhether orders from pest control firms and agricultural applications are increasingNeeds monitoring
📊 ProfitabilityGross profit trend relative to selling and logistics expensesCheck for improvement
⚖️ Regulatory environmentProduct usage conditions and regional regulatory requirementsSubject to change

It may take time for the new approach to rodent management to take root in field practices, and changes in regulatory requirements or product usage conditions could slow sales expansion. If online advertising and logistics costs rise on a limited customer base, loss burden may persist independent of revenue growth.

SenesTech is a company that simultaneously pursues a specific problem-solving approach through rodent fertility control and the expansion of online sales. The quality of revenue can be confirmed through recurring purchases and commercial customer growth, and it is necessary to continually review the cost efficiency of new channels and regulatory response.

Briefs · earnings · signals, first Subscribe
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →